Results 101 to 110 of about 28,403 (261)

Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua, Kristen Paradine, Craig A. Rohan, Mary McDaniel, Diane Perkins   +4 more
wiley   +1 more source

Atypical antipsychotics and anorexia nervosa: a review.

, 2010
BACKGROUND: There is currently mixed opinion regarding the value of using atypical antipsychotics to treat anorexia nervosa (AN). AIMS: To evaluate the literature on the use of atypical antipsychotics in AN.
McKnight, RF, Park, Rebecca
core   +1 more source

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aims Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with an increased risk of cardiovascular disease (CVD) morbidity and mortality. This study aimed to develop the first prediction models for CVD risk in a cohort of patients with MASH.
Joe Hollinghurst, Margarida Augusto, Fotis Tefos, Robert Bauer, Sreelatha Vadapalle, Lise Gehrt Cardél   +5 more
wiley   +1 more source

The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study

, 2010
BACKGROUND: \ud \ud Pituitary volume is currently measured as a marker of hypothalamic-pituitary-adrenal hyperactivity in patients with psychosis despite suggestions of susceptibility to antipsychotics.
Nicolo, John-Paul, Kerr, Melissa, McConchie, Mirabel, Wood, Stephen J., Pantelis, Christos, Markulev, Connie, McGorry, Patrick D., Proffitt, Tina-Marie, Berger, Gregor E., Garner, Belinda A., Velakoulis, Dennis   +10 more
core   +1 more source

Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma‐1 Receptor Modulation

The FEBS Journal, EarlyView.
We investigated the potential of iloperidone as an activator of Sigma‐1 receptor (S1R) neuroprotective function in juvenile Huntington's disease (jHD). We tested iloperidone on cortical neurons differentiated from patient‐derived iPSCs, demonstrating that it acts as a S1R agonist, decreasing apoptosis, huntingtin aggregation, and oxidative stress ...
Ersilia Fornetti, Gaia Galluzzi, Mario Frezzini, Cécile Exertier, Vittorio Brufani, Gianni Colotti, Giancarlo Ruocco, Jessica Rosati, Angelo Luigi Vescovi, Daniele Narzi, Ilaria Genovese, Andrea Ilari   +11 more
wiley   +1 more source

Reply: Atypical Antipsychotics and Neuroleptic Malignant Syndrome

, 2001
The epidemiology of Neuroleptic Malignant Syndrome (NMS) has been only recently examine das far as atypical antipsychotics are concerned. Further research is necessary regarding this clinical area, but preliminary data confim the risk of NMS by using ...
BIANCOSINO, Bruno, Bruno Biancosino, Luigi Grassi, GRASSI, Luigi   +3 more
core   +1 more source

Which atypical antipsychotic? [PDF]

British Journal of Psychiatry, 1998
C S, Thomas, S, Lewis
openaire   +2 more sources

Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis

Journal of Gastroenterology and Hepatology, EarlyView.
The first Australian guidance document on the assessment and management of idiopathic gastroparesis (IGP) reconceptualises IGP as a sensorimotor disorder. It proposes a novel multidisciplinary treatment algorithm and 20 high‐consensus recommendations, addressing common overlapping disorders, and providing clear guidance on associated disordered eating ...
Trina Kellar, Chamara Basnayake, Jessica Biesiekierski, Rebecca Burgell, Jessica Fitzpatrick, Geoffrey Hebbard, Vincent Ho, Hannah Kim, Simon R. Knowles, Christopher K. Rayner, May Wong, Nicholas J. Talley   +11 more
wiley   +1 more source

Baseline characteristics of patients exposed to risperidone, other atypical antipsychotics and typical antipsychotics.

, 2019
Baseline characteristics of patients exposed to risperidone, other atypical antipsychotics and typical antipsychotics.
Shih-Pei Shen (452242), Hung-Chi Wu (452238), Wen-Miin Liang (802427), Hong Qiu (315791), Kuan-Yi Tsai (452240), Meng Shu (7348661), Yanfang Liu (306148), Frank Huang-Chih Chou (7348664)   +7 more
core   +1 more source

The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.

PLoS ONE, 2019
ObjectiveAntipsychotic agents can increase circulating serum prolactin levels, potentially leading to osteoporosis and increased risk of bone fracture. The risk appears to be lower for atypical antipsychotics.
Shih-Pei Shen, Yanfang Liu, Hong Qiu, Kuan-Yi Tsai, Hung-Chi Wu, Wen-Miin Liang, Meng Shu, Frank Huang-Chih Chou   +7 more
doaj   +1 more source